[Is it permissible to use the combination urokinase-plasminogen by local administration in ischemias caused by popliteal or sub-popliteal thrombosis?].
D000328:Adult; D000368:Aged; D000792:Angiography; D001157:Arterial Occlusive Diseases / Q000175:diagnosis / Q000188:drug therapy*; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects; D006801:Humans; D007511:Ischemia / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010446:Peptide Fragments / Q000627:therapeutic use*; D010958:Plasminogen / Q000627:therapeutic use*; D011150:Popliteal Artery / Q000473:pathology*; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use*
D010446:Peptide Fragments; C018998:lysyl-plasminogen; D010958:Plasminogen; D014568:Urokinase-Type Plasminogen Activator
Est-il licite d'utiliser l'association urokinase-plasminogène par voie locale dans les ischémies par thrombose poplitées ou sous-poplitées?